Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 USD | +0.86% | -6.36% | -30.43% |
Apr. 12 | Uniqure N.V. Announces Paula Soteropoulos Will Not Stand for Re-Election as Non-Executive Director | CI |
Apr. 02 | UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.43% | 226M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure Says Initial Data From Phase 1/2 Trial Support Tolerability of AMT-130 in Patients With Huntington's Disease